Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT04231656
Eligibility Criteria:
Inclusion Criteria:
* Eligible and suitable for intermediate risk surgery, validated by anaesthesia consultation.
There is no definitive definition of intermediate risk. By reference to the literature, surgeries longer than 2 hours (excluding "low risk") and less than 3% postoperative mortality (excluding high-risk surgery). It includes the majority of non-serious visceral (abdominal and gynecological) surgery, plastic or cervical-facial surgery for neoplastic removal or long-term reconstruction, or long-term spinal surgery or neurosurgery of the base of the skull.
\- For which the anesthesiologist in charge has planned an invasive monitoring (radial catheter) of arterial blood pressure.
Exclusion Criteria:
* Urgent surgery
* Intracranial hypertension
* Orthostatic hypotension
* Extreme anthropometry: weight \>150 kg and 30 kg, size 120 cm and \>230 cm
* Related to NICCOMO monitoring:
* Rhythmic anomaly: Atrial fibrillation, tachycardia with heart rate \>200 beats per minute.
* Aortic disease: Severe sclerosis
* Valve dysfunction: severe aortic regurgitation,
* Patient with aortic prosthesis or pacemaker using impedance detection.
* Occurrence of tachycardia \> 200 bpm, occurrence of hypertension with mean arterial pressure \>130 mm Hg
* Simultaneous use of electrical cauterization systems during surgical procedures
* Septic shock
* Related to CLEARSIGHT monitoring
* Patient with prior distal perfusion disorders
* Lower extremity obliterans arteritis stage IV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04231656
Study Brief:
Protocol Section:
NCT04231656